Eden Research plc
LSE : EDE

September 30, 2011 02:00 ET

Marketing and licence agreements finalised with TerpeneTech

                                                                                     30 September 2011
                                                                             GB0001646941/GBP/PLUS-exn
                                                                                                      
                                                   
                                           EDEN RESEARCH PLC
                                         ("Eden" or "Company")

                      Marketing and licence agreements finalised with TerpeneTech

Eden  Research  plc, a leading UK agrochemical and encapsulation development company,  is  pleased  to
announce  that  it  has  signed the final marketing and licence agreements  with  TerpeneTech  Limited
("TerpeneTech").

As previously mentioned in the announcement made by Eden on 23 June 2011, the licence agreement grants
TerpeneTech the right to use Eden's terpene encapsulation system, for specific applications initially,
within  the consumer and agro-industrial biocide areas. A licence fee of €100,000 is payable  to  Eden
under the agreement, as well as on-going royalties on net sales of products.

The  marketing  agreement  provides TerpeneTech with access to Eden's  Geraniol,  Eugenol  and  Thymol
dossiers  for use with existing and new un-encapsulated consumer and agro-industrial biocide products,
in return for royalties on net sales.

Clive  Newitt, Managing Director of Eden, said, "TerpeneTech has already made significant progress  in
testing and formulating products in the biocides area using Eden's technology and we hope to see these
new products being commercialised quite soon.

Using  existing  relationships that the key players in TerpeneTech already have with large  businesses
provides the opportunity for significant product sales and, therefore, royalty income for Eden."

The Directors of Eden are responsible for the contents of this announcement.

Enquiries:

Eden Research plc                                                        01993 862761
Clive Newitt, Managing Director

St Helens Capital Partners LLP                                           020 7368 6959
Mark Anwyl



Notes:

Eden's strategy is focused on the development and commercialisation of its terpene-based encapsulation
technology  for  agricultural  and  non-agricultural  uses  through  appropriate  regional  or  global
partnerships.

Terpenes  are  natural  compounds which function as defence mechanisms in many plant  groups  and  are
released in response to infection, attack by pests, stress or mechanical injury. Terpenes are  already
widely used in the food flavouring, cosmetic and pharmaceutical industries.

Historically,  terpenes  have  had  limited commercial use in the agrochemical  sector  due  to  their
volatility,  phytotoxicity and poor solubility. Eden's platform encapsulation technology provides  the
unique,  natural  solution to these problems and enables terpenes to be used  as  effective,  low-risk
agrochemicals.


For more information about Eden, please visit www.edenresearch.com

Contact Information

  • Eden Research plc